Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 2.1T | 1.9T | 1.6T | 1.3T |
Cost of revenue | 2.0T | 1.7T | 1.5T | 1.2T |
Gross profit | 131.0B | 114.7B | 99.5B | 83.7B |
Operating expense | ||||
Research & development | 34.1B | 29.2B | 29.2B | 23.3B |
Selling general and admin | 32.4B | 30.8B | 25.7B | 23.6B |
Other operating expenses | — | — | — | — |
Operating income | 64.5B | 54.8B | 44.6B | 36.8B |
Non operating interest income | ||||
Income | 9.6B | 8.8B | 11.8B | 15.4B |
Expense | 8.1B | 8.8B | 9.3B | 10.6B |
Other income expense | — | — | — | — |
Pretax income | 63.3B | 67.7B | 48.4B | 32.5B |
Tax provision | 10.8B | 12.3B | 9.5B | 7.6B |
Net income | 52.5B | 55.3B | 38.9B | 24.9B |
Basic EPS | — | 3.6 | 2.5 | 1.6 |
Diluted EPS | — | 3.5 | 2.5 | 1.6 |
Basic average shares | — | 13.9B | 13.9B | 13.9B |
Diluted average shares | — | 14.0B | 14.0B | 14.1B |
EBITDA | 97.9B | 98.0B | 77.2B | 63.4B |
Net income from continuing op. | 63.3B | 67.7B | 48.4B | 32.5B |
Minority interests | -6.2B | -6.0B | -3.9B | -2.9B |
Preferred stock dividends | 0 | 0 | 0 | 0 |